LncRNA ZFAS1, as a poor prognostic indicator, promotes cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma
- PMID: 33151128
- DOI: 10.2217/pme-2020-0014
LncRNA ZFAS1, as a poor prognostic indicator, promotes cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma
Abstract
Background: Long noncoding RNA Zinc finger nuclear transcription factor, X-box binding 1-type containing 1 antisense RNA 1 (ZFAS1) has been reported to be an oncogene in various tumors. However, the role of ZFAS1 in endometrial carcinoma (EC) are not fully determined. Methods & results: Here, we found ZFAS1 expression was significantly upregulated in EC patients, which was significantly associated with International Federation of Gynecology and Obstetrics stage, histological grade, myometrial invasion and poor prognosis. The loss-of-function assays showed that knockdown of ZFAS1 significantly suppressed the proliferation, G1/S transition, migration and invasion in EC cells. Moreover, knockdown of ZFAS1 obviously downregulated the expression of CDK4, Cyclin D1 and N-cadherin, but upregulated E-cadherin expression. Conclusion: Collectively, these results suggest that ZFAS1 might be used as potential therapeutic targets for EC treatment.
Keywords: EMT; ZFAS1; bioinformatics; endometrial carcinoma; genomics; lncRNA; oncology; prognosis.
Similar articles
-
Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression.J Gastroenterol Hepatol. 2017 Jun;32(6):1204-1211. doi: 10.1111/jgh.13646. J Gastroenterol Hepatol. 2017. PMID: 27862275
-
Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and promotes glioma cell progression by activation of the Notch signaling pathway.Biomed Pharmacother. 2017 Mar;87:555-560. doi: 10.1016/j.biopha.2017.01.014. Epub 2017 Jan 9. Biomed Pharmacother. 2017. PMID: 28081466
-
Downregulation of lncRNA ZFAS1 inhibits the hallmarks of thyroid carcinoma via the regulation of miR‑302‑3p on cyclin D1.Mol Med Rep. 2021 Jan;23(1):2. doi: 10.3892/mmr.2020.11640. Epub 2020 Nov 12. Mol Med Rep. 2021. PMID: 33179076 Free PMC article.
-
Current insight into a cancer-implicated long noncoding RNA ZFAS1 and correlative functional mechanisms involved.Pathol Res Pract. 2018 Oct;214(10):1517-1523. doi: 10.1016/j.prp.2018.07.032. Epub 2018 Aug 1. Pathol Res Pract. 2018. PMID: 30122315 Review.
-
LncRNA ZFAS1: Role in tumorigenesis and other diseases.Biomed Pharmacother. 2021 Oct;142:111999. doi: 10.1016/j.biopha.2021.111999. Epub 2021 Aug 9. Biomed Pharmacother. 2021. PMID: 34385106 Review.
Cited by
-
Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma.Int J Gen Med. 2021 Nov 12;14:8073-8085. doi: 10.2147/IJGM.S338298. eCollection 2021. Int J Gen Med. 2021. PMID: 34803394 Free PMC article.
-
lncRNA-ZFAS1 promotes the progression of endometrial carcinoma by targeting miR-34b to regulate VEGFA expression.Open Med (Wars). 2021 Oct 4;16(1):1472-1481. doi: 10.1515/med-2021-0362. eCollection 2021. Open Med (Wars). 2021. PMID: 34703899 Free PMC article.
-
An update on the molecular mechanisms of ZFAS1 as a prognostic, diagnostic, or therapeutic biomarker in cancers.Discov Oncol. 2024 Jun 10;15(1):219. doi: 10.1007/s12672-024-01078-x. Discov Oncol. 2024. PMID: 38856786 Free PMC article. Review.
-
The Promotive and Inhibitory Role of Long Non-Coding RNAs in Endometrial Cancer Course-A Review.Cancers (Basel). 2024 Jun 3;16(11):2125. doi: 10.3390/cancers16112125. Cancers (Basel). 2024. PMID: 38893244 Free PMC article. Review.
-
Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature.Front Cell Dev Biol. 2022 Feb 1;9:814456. doi: 10.3389/fcell.2021.814456. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35178403 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials